POLISCOPE
Back to feed
FEDERALhearing transcript

Hearing on Department of Energy Research for COVID-19 Response

Original title: BIOLOGICAL RESEARCH AT THE DEPARTMENT OF ENERGY: LEVERAGING DOE'S UNIQUE CAPABILITIES TO RESPOND TO THE COVID-19 PANDEMIC

January 1, 2020

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing reviews the federal government's strategy for utilizing national laboratory resources to accelerate scientific research and technological solutions during the COVID-19 public health crisis.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Department of Energy National Laboratories

These facilities are tasked with pivoting research priorities to address COVID-19 response efforts.

Scientific Research Community

Researchers are impacted by the shift in federal funding and focus toward pandemic-related biological studies.

What changed

Last recorded activity January 1, 2020.

What's next

Next step not available in the current record.

Summary

The House held a hearing to examine how the Department of Energy's national laboratories are using their unique scientific capabilities, such as supercomputing and biological research, to address the COVID-19 pandemic.

Key Facts

  • The hearing was held on September 11, 2020, by the Subcommittee on Energy.
  • The purpose was to discuss leveraging Department of Energy (DOE) national laboratory capabilities for COVID-19 response.
  • DOE national laboratories are noted for capabilities in supercomputing, material science, and biological research.
  • The hearing was conducted virtually via Webex due to pandemic-related protocols.
  • Four expert witnesses provided testimony regarding biological research and microbiology.
  • The hearing record includes a formal charter and post-hearing questions answered by Dr. Mary Maxon.

Frequently Asked Questions

What is the role of the Department of Energy in a pandemic?
The Department of Energy utilizes its national laboratories to conduct advanced biological research and provide supercomputing power to help understand and respond to health crises like COVID-19.
Who testified at this hearing?
The witnesses included Dr. Mary Maxon (Lawrence Berkeley National Laboratory), Dr. Debra Mohnen (University of Georgia), Dr. Glenn C. Randall (University of Chicago), and Dr. Kelly C. Wrighton (Colorado State University).

Why It Matters

This hearing reviews the federal government's strategy for utilizing national laboratory resources to accelerate scientific research and technological solutions during the COVID-19 public health crisis.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Repurposing National Labs

The hearing highlights a strategic shift in the mission of DOE national laboratories from energy-specific research to broader biological and pandemic-response research.

Connected Entities

personFrank D. LucasRanking Member of the Committee on Science, Space, and TechnologyMap →
personMary MaxonAssociate Laboratory Director for Biosciences, Lawrence Berkeley National LaboraMap →
organizationHouse Committee on Science, Space, and TechnologyCongressional committee conducting the hearingMap →
organizationDepartment of EnergyFederal agency overseeing national laboratoriesMap →
personLizzie FletcherChairwoman of the Subcommittee on EnergyMap →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record